Literature DB >> 15893719

Socioeconomic factors in lupus erythematosus.

Stephan Meller1, Bernhard Homey, Thomas Ruzicka.   

Abstract

For a long time, systemic lupus erythematosus (SLE) was considered a potentially deadly disease. Since the introduction of immunosuppressive therapy, the life expectancy and the quality of life of patients suffering from lupus erythematosus has been dramatically improved. Today, the 5-year survival rate for SLE varies between 50% and 95%. Still, not all patients benefit equally from medical advances. Ethnic and/or socioeconomic minorities show severely disadvantageous prognosis or outcome in various studies. A substantial reduction in the quality of life as well as unemployment are other frequent side effects of this disease. Vocational handicaps related to discoid lupus erythematodes (DLE) was seen in nearly 45% of the patients. Therefore, the management of lupus erythematosus patients requires interdisciplinary cooperation between physicians, psychologists and social workers. The major aim of this article is to summarize the history of lupus erythematosus on the one and the other hand to consider the role of the socioeconomic factors influencing the prognosis of systemic and cutaneous lupus erythematosus.

Entities:  

Mesh:

Year:  2004        PMID: 15893719     DOI: 10.1016/j.autrev.2004.11.008

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  5 in total

1.  Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis.

Authors:  Laura M Chang; Prateesh Maheshwari; Sheila Werth; Lana Schaffer; Steven R Head; Carrie Kovarik; Victoria P Werth
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

2.  Burden of Systemic Lupus Erythematosus on Work Productivity and Daily Living Activity: A Cross-Sectional Study Among Malaysian Multi-Ethnic Cohort.

Authors:  Fakhriah Abu Bakar; Syahrul Sazliyana Shaharir; Rozita Mohd; Mohd Shahrir Mohamed Said; Sakthiswary Rajalingham; Kong Wei Yen
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

3.  Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).

Authors:  L B Tucker; A G Uribe; M Fernández; L M Vilá; G McGwin; M Apte; B J Fessler; H M Bastian; J D Reveille; G S Alarcón
Journal:  Lupus       Date:  2008-04       Impact factor: 2.911

4.  Serum amyloid A-to-albumin ratio as a potential biomarker to predict the activity, severity, and poor prognosis of systemic lupus erythematosus.

Authors:  Liang Zhao; Qun Zhang; Zhigang Feng; Jinshan Zhang; Feng He
Journal:  J Clin Lab Anal       Date:  2022-02-10       Impact factor: 2.352

5.  Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus.

Authors:  Mathilda Björk; Örjan Dahlström; Jonas Wetterö; Christopher Sjöwall
Journal:  BMC Musculoskelet Disord       Date:  2015-08-12       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.